» Articles » PMID: 32436865

The Hamster Egg Penetration Test May Decrease Intracytoplasmic Sperm Injection Utilization While Maintaining High Conventional Fertilization Rates

Overview
Journal Asian J Androl
Specialty Urology
Date 2020 May 22
PMID 32436865
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

This was a cohort study of in vitro fertilization (IVF) subjects at the University of Utah, Salt Lake City (UT, USA) utilizing partner sperm. Cycles where both the hamster egg penetration test (HEPT) and semen analysis were performed within 2 years prior to IVF cycles were stratified into four groups based on a normal or an abnormal HEPT and morphology. The mean conventional and intracytoplasmic sperm injection (ICSI) fertilization rates were calculated in each group. We performed a univariate analysis on the primary outcome comparing clinically interesting subjects. We performed a cost-effectiveness analysis of a policy of HEPT versus universal ICSI in couples with an abnormal morphology. Among patients with a normal HEPT, there was no difference in the mean conventional fertilization rates between those with a normal and an abnormal morphology. There was no difference in the mean conventional fertilization rates between subjects with a normal morphology without a hamster test and those with a normal HEPT without a morphology assessment. In 1000 simulated cycles with an abnormal morphology, a policy of HEPT was cost saving compared to universal ICSI, yet produced similar fertilization rates. The HEPT is similar to the World Health Organization edition 5 (WHO-5) morphology in predicting successful conventional fertilization while allowing decreased utilization of ICSI. A policy of HEPT for males with abnormal morphology saves cost in selecting couples for a fertilization method.

Citing Articles

The correlation between sperm percentage with a small acrosome and unexplained in vitro fertilization failure.

Li C, Ni Y, Yao L, Fang J, Jiang N, Chen J BMC Pregnancy Childbirth. 2024; 24(1):58.

PMID: 38212716 PMC: 10782770. DOI: 10.1186/s12884-023-06205-0.

References
1.
Jain T, Gupta R . Trends in the use of intracytoplasmic sperm injection in the United States. N Engl J Med. 2007; 357(3):251-7. DOI: 10.1056/NEJMsa070707. View

2.
Bhattacharya S, Hamilton M, Shaaban M, Khalaf Y, Seddler M, Ghobara T . Conventional in-vitro fertilisation versus intracytoplasmic sperm injection for the treatment of non-male-factor infertility: a randomised controlled trial. Lancet. 2001; 357(9274):2075-9. DOI: 10.1016/s0140-6736(00)05179-5. View

3.
Devroey P, VAN Steirteghem A . A review of ten years experience of ICSI. Hum Reprod Update. 2004; 10(1):19-28. DOI: 10.1093/humupd/dmh004. View

4.
Ajduk A, Yamauchi Y, Ward M . Sperm chromatin remodeling after intracytoplasmic sperm injection differs from that of in vitro fertilization. Biol Reprod. 2006; 75(3):442-51. DOI: 10.1095/biolreprod.106.053223. View

5.
Hewitson L, Schatten G . The use of primates as models for assisted reproduction. Reprod Biomed Online. 2002; 5(1):50-5. DOI: 10.1016/s1472-6483(10)61598-2. View